The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 9 of 40
Back to Result List

Improvement of left ventricular ejection fraction in revascularized postmyocardial patients

  • BACKGROUND: Reduced left ventricular ejection fraction (LVEF) ≤30% is the most powerful prognostic indicator for sudden cardiac death (SCD) in patients after myocardial infarction (MI), but there are little data about long-term changes of LVEF after revascularization and the following implantation of a cardioverter defibrillator (ICD). METHODS: We performed a retrospective analysis of 277 patients with reduced LVEF at least 1month after MI and complete revascularization. Patients (median time post-MI 23.4months; 74.3% after PCI, 25.7% after CABG were assigned either to group 1 (LVEF<30%) or group 2 (LVEF 30-40%). Biplane echocardiography was redone after a mean follow-up of 441±220days. RESULTS: LVEF increased significantly in both two groups (group 1: 26.2±4.8% to 32.4±8.5%; p<0.001; group 2: 38.2±2.5% to 44.4±9.6%; p<0.001). However, statistical analysis of first and second LVEF measurement by means of a LOWESS regression and with an appropriate correction of the regression towards the mean effect revealed only a moderateBACKGROUND: Reduced left ventricular ejection fraction (LVEF) ≤30% is the most powerful prognostic indicator for sudden cardiac death (SCD) in patients after myocardial infarction (MI), but there are little data about long-term changes of LVEF after revascularization and the following implantation of a cardioverter defibrillator (ICD). METHODS: We performed a retrospective analysis of 277 patients with reduced LVEF at least 1month after MI and complete revascularization. Patients (median time post-MI 23.4months; 74.3% after PCI, 25.7% after CABG were assigned either to group 1 (LVEF<30%) or group 2 (LVEF 30-40%). Biplane echocardiography was redone after a mean follow-up of 441±220days. RESULTS: LVEF increased significantly in both two groups (group 1: 26.2±4.8% to 32.4±8.5%; p<0.001; group 2: 38.2±2.5% to 44.4±9.6%; p<0.001). However, statistical analysis of first and second LVEF measurement by means of a LOWESS regression and with an appropriate correction of the regression towards the mean effect revealed only a moderate increase of the mean LVEF from 35 to 37% (p<0.001) with a large interindividual variation. CONCLUSIONS: The impact of early revascularization on LVEF appears to be low in the majority of post-MI heart failure patients. Owing to the high variability, a single measurement may not be reliable enough to justify a decision on ICD indication.show moreshow less

Download full text files

  • pmnr882.pdfeng
    (1301KB)

    SHA-1: 659b0643f73f5b8a5723b34e2166c40a9c7aa393

Export metadata

Additional Services

Search Google Scholar Statistics
Metadaten
Author details:Rona Katharina ReibisORCiDGND, Annett SalzwedelORCiDGND, Klaus BonaventuraORCiDGND, Heinz VöllerORCiDGND, Karl WegscheiderORCiDGND
URN:urn:nbn:de:kobv:517-opus4-435093
DOI:https://doi.org/10.25932/publishup-43509
ISSN:1866-8372
Title of parent work (German):Postprints der Universität Potsdam : Mathematisch Naturwissenschaftliche Reihe
Subtitle (English):indication for statistical fallacy
Publication series (Volume number):Zweitveröffentlichungen der Universität Potsdam : Mathematisch-Naturwissenschaftliche Reihe (882)
Publication type:Postprint
Language:English
Publication year:2017
Publishing institution:Universität Potsdam
Release date:2020/04/15
Tag:cardioverter-defibrillator; heart failure; myocardial infarction; regression toward the mean
Issue:882
Number of pages:10
Source:BMC Research Notes 10 (2017) 244 DOI: 10.1186/s13104-017-2562-4
Organizational units:Mathematisch-Naturwissenschaftliche Fakultät
DDC classification:5 Naturwissenschaften und Mathematik / 57 Biowissenschaften; Biologie / 570 Biowissenschaften; Biologie
6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Peer review:Referiert
Publishing method:Open Access
License (German):License LogoCC-BY - Namensnennung 4.0 International
Accept ✔
This website uses technically necessary session cookies. By continuing to use the website, you agree to this. You can find our privacy policy here.